- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x YG1: N-{(11S)-2-[2-(5-hydroxypent-1-yn-1-yl)phenyl]-4H,10H-pyrazolo[5,1-c][1,4]benzoxazepin-7-yl}acetamide(Non-covalent)
- 4 x FBP: 1,6-di-O-phosphono-beta-D-fructofuranose(Non-covalent)
FBP.2: 17 residues within 4Å:- Chain A: A.409, R.470, G.497, F.498, T.527, I.528, S.529, N.531, M.572, G.574, E.628, H.660, Q.663, R.734
- Chain B: T.562, R.565, R.654
15 PLIP interactions:2 interactions with chain B, 13 interactions with chain A- Salt bridges: B:R.565, B:R.654, A:R.470, A:R.470, A:H.660, A:R.734
- Hydrogen bonds: A:R.470, A:R.470, A:T.527, A:S.529, A:N.531, A:G.574, A:E.628, A:E.628, A:Q.663
FBP.6: 17 residues within 4Å:- Chain A: T.562, R.565, R.654
- Chain B: A.409, R.470, G.497, F.498, T.527, I.528, S.529, N.531, M.572, G.574, E.628, H.660, Q.663, R.734
16 PLIP interactions:14 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:R.470, B:R.470, B:T.527, B:T.527, B:S.529, B:N.531, B:G.574, B:E.628, B:E.628, B:Q.663
- Salt bridges: B:R.470, B:R.470, B:H.660, B:R.734, A:R.565, A:R.654
FBP.10: 17 residues within 4Å:- Chain C: A.409, R.470, G.497, F.498, T.527, I.528, S.529, N.531, M.572, G.574, E.628, H.660, Q.663, R.734
- Chain D: T.562, R.565, R.654
15 PLIP interactions:13 interactions with chain C, 2 interactions with chain D- Hydrogen bonds: C:R.470, C:R.470, C:T.527, C:S.529, C:N.531, C:G.574, C:E.628, C:E.628, C:Q.663
- Salt bridges: C:R.470, C:R.470, C:H.660, C:R.734, D:R.565, D:R.654
FBP.14: 17 residues within 4Å:- Chain C: T.562, R.565, R.654
- Chain D: A.409, R.470, G.497, F.498, T.527, I.528, S.529, N.531, M.572, G.574, E.628, H.660, Q.663, R.734
16 PLIP interactions:14 interactions with chain D, 2 interactions with chain C- Hydrogen bonds: D:R.470, D:R.470, D:T.527, D:T.527, D:S.529, D:N.531, D:G.574, D:E.628, D:E.628, D:Q.663
- Salt bridges: D:R.470, D:R.470, D:H.660, D:R.734, C:R.565, C:R.654
- 4 x F6P: 6-O-phosphono-beta-D-fructofuranose(Post Translational Modification)
F6P.3: 10 residues within 4Å:- Chain A: G.25, I.165, D.166, M.208, R.210, E.264, H.298, R.301
- Chain B: R.201, R.292
7 PLIP interactions:5 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:D.166, A:E.264, A:R.301
- Salt bridges: A:H.298, A:R.301, B:R.201, B:R.292
F6P.7: 10 residues within 4Å:- Chain A: R.201, R.292
- Chain B: G.25, I.165, D.166, M.208, R.210, E.264, H.298, R.301
7 PLIP interactions:2 interactions with chain A, 5 interactions with chain B- Salt bridges: A:R.201, A:R.292, B:H.298, B:R.301
- Hydrogen bonds: B:D.166, B:E.264, B:R.301
F6P.11: 10 residues within 4Å:- Chain C: G.25, I.165, D.166, M.208, R.210, E.264, H.298, R.301
- Chain D: R.201, R.292
7 PLIP interactions:2 interactions with chain D, 5 interactions with chain C- Salt bridges: D:R.201, D:R.292, C:H.298, C:R.301
- Hydrogen bonds: C:D.166, C:E.264, C:R.301
F6P.15: 10 residues within 4Å:- Chain C: R.201, R.292
- Chain D: G.25, I.165, D.166, M.208, R.210, E.264, H.298, R.301
7 PLIP interactions:2 interactions with chain C, 5 interactions with chain D- Salt bridges: C:R.201, C:R.292, D:H.298, D:R.301
- Hydrogen bonds: D:D.166, D:E.264, D:R.301
- 4 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
ADP.4: 16 residues within 4Å:- Chain A: S.23, G.24, G.25, Y.55, R.88, C.89, F.92, T.93, R.98, G.118, D.119, G.120, S.121, T.123, G.124, I.127
11 PLIP interactions:11 interactions with chain A- Hydrogen bonds: A:G.25, A:C.89, A:C.89, A:T.93, A:G.118, A:G.118, A:D.119, A:G.120, A:S.121, A:S.121
- Salt bridges: A:R.88
ADP.8: 16 residues within 4Å:- Chain B: S.23, G.24, G.25, Y.55, R.88, C.89, F.92, T.93, R.98, G.118, D.119, G.120, S.121, T.123, G.124, I.127
11 PLIP interactions:11 interactions with chain B- Hydrogen bonds: B:G.25, B:C.89, B:C.89, B:T.93, B:G.118, B:D.119, B:D.119, B:G.120, B:S.121, B:S.121
- Salt bridges: B:R.88
ADP.12: 16 residues within 4Å:- Chain C: S.23, G.24, G.25, Y.55, R.88, C.89, F.92, T.93, R.98, G.118, D.119, G.120, S.121, T.123, G.124, I.127
11 PLIP interactions:11 interactions with chain C- Hydrogen bonds: C:G.25, C:C.89, C:C.89, C:T.93, C:G.118, C:G.118, C:D.119, C:G.120, C:S.121, C:S.121
- Salt bridges: C:R.88
ADP.16: 16 residues within 4Å:- Chain D: S.23, G.24, G.25, Y.55, R.88, C.89, F.92, T.93, R.98, G.118, D.119, G.120, S.121, T.123, G.124, I.127
11 PLIP interactions:11 interactions with chain D- Hydrogen bonds: D:G.25, D:C.89, D:C.89, D:T.93, D:G.118, D:D.119, D:D.119, D:G.120, D:S.121, D:S.121
- Salt bridges: D:R.88
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Amara, N. et al., Selective activation of PFKL suppresses the phagocytic oxidative burst. Cell (2021)
- Release Date
- 2022-01-26
- Peptides
- ATP-dependent 6-phosphofructokinase, liver type: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
DC
ED
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x YG1: N-{(11S)-2-[2-(5-hydroxypent-1-yn-1-yl)phenyl]-4H,10H-pyrazolo[5,1-c][1,4]benzoxazepin-7-yl}acetamide(Non-covalent)
- 4 x FBP: 1,6-di-O-phosphono-beta-D-fructofuranose(Non-covalent)
- 4 x F6P: 6-O-phosphono-beta-D-fructofuranose(Post Translational Modification)
- 4 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Amara, N. et al., Selective activation of PFKL suppresses the phagocytic oxidative burst. Cell (2021)
- Release Date
- 2022-01-26
- Peptides
- ATP-dependent 6-phosphofructokinase, liver type: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
DC
ED
F